MDD XR 50 Tablet: Long-Acting Relief for Major Depressive Disorder

MDD XR 50 Tablet contains desvenlafaxine (50mg), a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder (MDD). This extended-release formulation provides consistent, controlled delivery of the medication throughout the day, reducing the frequency of dosing and improving patient adherence.

Key Benefits:

* Effective treatment for MDD: Reduces symptoms like low mood, lack of energy, fatigue, and feelings of hopelessness.
* Long-acting relief: Provides continuous improvement in symptoms over extended periods with fewer doses needed.
* Improved Adherence: Consistent dosing reduces the need for frequent medication reminders, leading to better compliance and therapeutic effect.

Consult your healthcare professional: MDD XR is for use only under the guidance of a qualified medical practitioner.

Please note: This information is not a substitute for professional medical advice. Always consult with your doctor or pharmacist before starting any new medications.